35G Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genpact Ltd

Watchlist Manager

Watchlist

Price: 32.26 EUR -2.71% Market Closed

Market Cap: €6.1B

G	Genpact Ltd XBER:35G	BM
P	Procore Technologies Inc F:5PT	US
	Austco Healthcare Ltd ASX:AHC	AU
L	Leifheit AG LSE:0F2Z	DE
W	Wise Ltd NASDAQ:WSE	UK
	Ovid Therapeutics Inc NASDAQ:OVID	US

Profitability Summary

Genpact Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

36%

Sustainable 3Y Average Gross Margin

36%

Gross Margin is Increasing

35% > 36%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

13% > 15%

Healthy Net Margin

11%

Sustainable 3Y Average Net Margin

12%

Net Margin is Increasing

9% > 11%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

12% > 13%

Positive ROE

23%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

14%

ROIC is Increasing

11% > 13%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.